Autor/in / Beteiligte Person: |
Chianelli, M ; Busetto, L ; Vettor, R ; Annibale, B ; Paoletta, A ; Papini, E ; Albanese, A ; Carabotti, M ; Casarotto, D ; De Pergola, G ; Disoteo, OE ; Grandone, I ; Medea, G ; Nisoli, E ; Raffaelli, M ; Schiff, S ; Vignati, F ; Cinquini, M ; Gonzalez-Lorenzo, M ; Fittipaldo, VA ; Minozzi, S ; Monteforte, M ; Tralongo, AC ; Novizio, R ; Persichetti, A ; Samperi, I ; Scoppola, A ; Borretta, G ; Carruba, M ; Carbonelli, MG ; De Luca, M ; Frontoni, S ; Corradini, SG ; Muratori, F ; Attanasio, R |
Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Systematic Review; Practice Guideline
- Language: English
- [J Endocrinol Invest] 2024 Jun; Vol. 47 (6), pp. 1361-1371. <i>Date of Electronic Publication: </i>2024 Apr 17.
- MeSH Terms: Obesity* / therapy ; Obesity* / complications ; Obesity* / epidemiology ; Overweight* / therapy ; Overweight* / complications ; Overweight* / epidemiology ; Humans ; Adult ; Italy / epidemiology ; Comorbidity ; Behavior Therapy / methods ; Behavior Therapy / standards ; Practice Guidelines as Topic / standards ; Disease Management ; Bariatric Surgery / methods
- References: World Health Organization. Regional Office for Europe. (2022) WHO European Regional Obesity Report 2022. World Health Organization. Regional Office for Europe. https://apps.who.int/iris/handle/10665/353747 . License: CC BY-NC-SA 3.0 IGO. . ; (2022) 3. Prevention or delay of type 2 diabetes and associated comorbidities: standards of medical care in diabetes—2022. Diabetes Care 45 S39–S45. ; Hostalek U (2019) Global epidemiology of prediabetes-present and future perspectives. Clin Diabetes Endocrinol 5:5 https://doi.org/10.1186/s40842-019-0080-0. (PMID: 10.1186/s40842-019-0080-0310866776507173) ; Schlesinger S et al (2022) Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies. Diabetologia 65:275–285. (PMID: 3471883410.1007/s00125-021-05592-3) ; Rinella ME et al (2023) A multisociety delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79:1542–1556. (PMID: 3736479010.1016/j.jhep.2023.06.003) ; Bedogni G et al (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33. (PMID: 17081293163665110.1186/1471-230X-6-33) ; Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME (2015) Obesity-induced hypertension. Circ Res 116:991–1006. (PMID: 25767285436308710.1161/CIRCRESAHA.116.305697) ; Coatmellec-Taglioni G, Ribière C (2003) Factors that influence the risk of hypertension in obese individuals. Curr Opin Nephrol Hypertens 12:305–308. (PMID: 1269807010.1097/00041552-200305000-00013) ; De Pergola G, Nardecchia A, Guida P, Silvestris F (2011) Arterial hypertension in obesity: relationships with hormone and anthropometric parameters. Eur J Cardiovasc Prev Rehabil 18:240–247. (PMID: 2145067110.1177/1741826710389367) ; Mouton AJ, Li X, Hall ME, Hall JE (2020) Obesity, hypertension, and cardiac dysfunction. Circ Res 126:789–806. (PMID: 32163341725505410.1161/CIRCRESAHA.119.312321) ; Fantin F et al (2019) Weight loss and hypertension in obese subjects. Nutrients 11:1667. (PMID: 31330870668292310.3390/nu11071667) ; Kushner RF, Foster GD (2000) Obesity and quality of life. Nutrition 16:947–952. (PMID: 1105460010.1016/S0899-9007(00)00404-4) ; Kolotkin RL, Andersen JR (2017) A systematic review of reviews: exploring the relationship between obesity, weight loss and health-related quality of life. Clin Obes 7:273–289. (PMID: 28695722560009410.1111/cob.12203) ; Onyike CU (2003) Is obesity associated with major depression? results from the third national health and nutrition examination survey. Am J Epidemiol 158:1139–1147. (PMID: 1465229810.1093/aje/kwg275) ; Perdomo CM, Cohen RV, Sumithran P, Clément K, Frühbeck G (2023) Contemporary medical, device, and surgical therapies for obesity in adults. The Lancet 401:1116–1130. (PMID: 10.1016/S0140-6736(22)02403-5) ; O’Brien PD, Hinder LM, Callaghan BC, Feldman EL (2017) Neurological consequences of obesity. Lancet Neurol 16:465–477. (PMID: 28504110565739810.1016/S1474-4422(17)30084-4) ; Jansen A, Houben K, Roefs AA (2015) Cognitive profile of obesity and its translation into new interventions. Front Psychol. https://doi.org/10.3389/fpsyg.2015.01807. (PMID: 10.3389/fpsyg.2015.01807266404514661286) ; Schiff S et al (2016) Impulsivity toward food reward is related to BMI: evidence from intertemporal choice in obese and normal-weight individuals. Brain Cogn 110:112–119. (PMID: 2652509610.1016/j.bandc.2015.10.001) ; Bessell E, Markovic TP, Fuller NR (2021) How to provide a structured clinical assessment of a patient with overweight or obesity. Diabetes Obes Metab 23:36–49. (PMID: 3362141310.1111/dom.14230) ; Busetto L et al (2022) Updating obesity management strategies: an audit of Italian specialists. Eat Weight Disord Studies Anorex Bulim Obes 27:2653–2663. (PMID: 10.1007/s40519-022-01402-w) ; Sharma AM, Kushner RF (2009) A proposed clinical staging system for obesity. Int J Obes 33:289–295. (PMID: 10.1038/ijo.2009.2) ; Kastorini C-M et al (2011) The effect of mediterranean diet on metabolic syndrome and its components. J Am Coll Cardiol 57:1299–1313. (PMID: 2139264610.1016/j.jacc.2010.09.073) ; Muscogiuri G et al (2021) European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts 14:222–245. (PMID: 33882506813819910.1159/000515381) ; Piercy KL et al (2018) The physical activity guidelines for Americans. JAMA 320:2020. (PMID: 30418471958263110.1001/jama.2018.14854) ; Douketis JD, Feightner JW, Attia J, Feldman WF (1999) Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. CMAJ 160:513–525. (PMID: 100814681230077) ; Jensen MD et al (2014) 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation. https://doi.org/10.1161/01.cir.0000437739.71477.ee. (PMID: 10.1161/01.cir.0000437739.71477.ee25602953) ; Guerciolini R (1997) Mode of action of orlistat. Int J Obes Relat Metab Disord 21:S12-23. (PMID: 9225172) ; Zhi J et al (1994) Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 56:82–85. (PMID: 803349810.1038/clpt.1994.104) ; EMA (2011) European Medicines Agency starts review of orlistat-containing medicines. Evidence relating to very rare cases of liver injury to be considered in depth. EMA/CHMP/771335/2011. https://www.ema.europa.eu/en/news/european-medicines-agency-starts-review-orlistat-containing-medicines. ; O’Neil PM et al (2018) Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet 392:637–649. (PMID: 10.1016/S0140-6736(18)31773-2) ; Arterburn DE, Telem DA, Kushner RF, Courcoulas AP (2020) Benefits and risks of bariatric surgery in adults. JAMA 324:879. (PMID: 3287030110.1001/jama.2020.12567) ; Welbourn R et al (2019) Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018. Obes Surg 29:782–795. (PMID: 3042132610.1007/s11695-018-3593-1) ; De Luca M et al (2021) IFSO update position statement on one anastomosis gastric bypass (OAGB). Obes Surg 31:3251–3278. (PMID: 3393905910.1007/s11695-021-05413-x) ; Furbetta N, Cervelli R, Furbetta F (2020) Laparoscopic adjustable gastric banding, the past, the present and the future. Ann Transl Med 8:S4–S4. (PMID: 32309408715432210.21037/atm.2019.09.17) ; Surve A et al (2020) Long-term outcomes of primary single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). Surg Obes Relat Dis 16:1638–1646. (PMID: 3284326610.1016/j.soard.2020.07.019) ; Guyatt GH et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926. (PMID: 18436948233526110.1136/bmj.39489.470347.AD) ; Brouwers MC et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J 182:E839–E842. (PMID: 10.1503/cmaj.090449) ; Cochrane Handbook for Systematic Reviews of Interventions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (Wiley, 2019). ISBN:9781119536604. https://doi.org/10.1002/9781119536604. ; Torgerson JS, Hauptman J, Boldrin MN, Sjöström L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care 27:155–161. (PMID: 1469398210.2337/diacare.27.1.155) ; Iannazzo S, Zaniolo O, Pradelli L (2008) Economic evaluation of treatment with orlistat in Italian obese patients. Curr Med Res Opin 24:63–74. (PMID: 1802149110.1185/030079908X253591) ; Nathan DM, Lachin JM, Balasubramanyam A, Burch HB, Buse JB, Butera NM, Cohen RM, Crandall JP, Kahn SE, Krause-Steinrauf H, Larkin ME, Rasouli N, Tiktin M, Wexler DJ, Younes N, GRADE Study Research Group (2022) Glycemia reduction in type 2 diabetes — glycemic outcomes. New Eng J Med 387:1063–1074. (PMID: 3612999610.1056/NEJMoa2200433) ; Kim N et al (2022) Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States. J Manag Care Spec Pharm 28:740–752. (PMID: 35737858) ; Greenway FL et al (2010) Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 376:595–605. (PMID: 10.1016/S0140-6736(10)60888-4) ; Roh SY, Park YH, Lee WK, Kim SM (2020) Patient preferences regarding bariatric/metabolic procedures: a survey of Korean obese candidates for surgery. Ann Surg Treat Res 98:82. (PMID: 32051816700287910.4174/astr.2020.98.2.82) ; Sarwer DB et al (2012) Physicians’ attitudes about referring their type 2 diabetes patients for bariatric surgery. Surg Obes Relat Dis 8:381–386. (PMID: 2238692610.1016/j.soard.2011.12.013) ; Arterburn D et al (2013) A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes. Surg Obes Relat Dis 9:837–844. (PMID: 2391134510.1016/j.soard.2013.05.006) ; Coulman KD, MacKichan F, Blazeby JM, Donovan JL, Owen-Smith A (2020) Patients’ experiences of life after bariatric surgery and follow-up care: a qualitative study. BMJ Open 10:e035013. (PMID: 32034030704527110.1136/bmjopen-2019-035013) ; Engström Å, Forsberg A (2018) Patients’ perceptions of short-term recovery after a gastric bypass. J Perianesth Nurs 33:681–688. (PMID: 3023657610.1016/j.jopan.2017.05.008) ; Haddad A et al (2021) The IFSO worldwide one anastomosis gastric bypass survey: techniques and outcomes? Obes Surg 31:1411–1421. (PMID: 3351755710.1007/s11695-021-05249-5)
- Contributed Indexing: Keywords: Bariatric surgery; Liraglutide; Naltrexone–bupropion; Obesity; Orlistat; Semaglutide
- Entry Date(s): Date Created: 20240417 Date Completed: 20240601 Latest Revision: 20240603
- Update Code: 20240604
|